-
Substance P in Pain Transmission Research: Applied Workflows
2026-05-25
Substance P is a gold-standard tachykinin neuropeptide for dissecting pain, inflammation, and immune signaling in the CNS. This article delivers bench-proven workflows, protocol optimizations, and troubleshooting strategies that maximize experimental reproducibility and translational relevance.
-
AMPK Suppresses ULK1 to Regulate Autophagy Under Energy Stre
2026-05-24
This study redefines the role of AMPK in autophagy by demonstrating that, contrary to prevailing models, AMPK inhibits rather than activates ULK1 and autophagy during energy stress. The findings reshape our understanding of energy-sensing pathways in cellular homeostasis and have practical implications for experimental autophagy modulation.
-
Dehydroepiandrosterone (DHEA): Applied Workflows in Neuropro
2026-05-23
Dehydroepiandrosterone (DHEA) is redefining experimental models in neuroprotection and ovarian biology, offering robust platforms for studying apoptosis inhibition and follicular development. This article delivers actionable protocols, highlights a key innovation in PCOS research, and provides troubleshooting insights to maximize DHEA's translational value.
-
Degarelix Acetate: Precision GnRH Antagonist Workflows in Re
2026-05-22
Degarelix acetate empowers hormone pathway researchers with highly selective, rapid, and sustained GnRH receptor inhibition for both in vitro and in vivo studies. This article unpacks optimized protocols, troubleshooting strategies, and actionable insights—translating the latest evidence and product capabilities into robust experimental outcomes.
-
JNK-IN-7: Selective JNK Inhibitor for Apoptosis Pathway Rese
2026-05-22
JNK-IN-7 enables researchers to precisely dissect JNK-driven signaling in apoptosis, inflammation, and innate immune models. Its covalent, highly selective inhibition offers reproducibility and pathway clarity, especially in complex cell-based assays and translational studies.
-
Ruxolitinib Triggers Caspase-Dependent Cell Death in ATC via
2026-05-21
This study demonstrates that ruxolitinib induces both apoptosis and GSDME-mediated pyroptosis in anaplastic thyroid carcinoma (ATC) by transcriptionally inhibiting DRP1, disrupting mitochondrial fission through suppression of JAK1/2-STAT3 signaling. The findings provide a mechanistic foundation for targeting mitochondrial dynamics and caspase pathways in highly malignant thyroid cancers.
-
Antimycin A4: ATP-Citrate Lyase Inhibitor for Metabolic Stud
2026-05-21
Antimycin A4 offers unparalleled precision for dissecting ATP-citrate lyase and mitochondrial function, enabling advanced metabolic and cytotoxicity research. This article delivers actionable protocols, troubleshooting strategies, and translational insights for researchers seeking robust, reproducible results.
-
Bone Transport Enhances DFU Healing via TGF-β1 Pathway Coupl
2026-05-20
This study demonstrates that bone transport accelerates diabetic foot ulcer (DFU) healing by activating TGF-β1-mediated angiogenic and osteo-immune coupling. The findings establish a mechanistic link between bone-driven signaling and reparative processes in chronic wound repair, highlighting the TGF-β1/TGFBR1 axis as a promising therapeutic target.
-
Busulfan in Germ Cell Depletion: Mechanistic Nuance & Assay
2026-05-20
Explore Busulfan’s unique mechanism as a DNA alkylating agent for precision germ cell depletion and senescence models. This article reveals advanced insights into MAPK pathway activation, experimental design, and the latest genetic tracing findings to guide your research.
-
Topotecan and Etoposide: Mechanistic Insights in DNA Damage
2026-05-19
The referenced review details the pharmacological innovation and clinical deployment of topotecan, a topoisomerase I inhibitor, in oncology. It highlights the mechanistic contrasts with topoisomerase II inhibitors like etoposide, informing experimental choices in DNA damage and apoptosis research.
-
Technical Use of Angiotensin I/II (1-5) in RAS Research
2026-05-19
Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for precise modeling of blood pressure regulation and aldosterone stimulation within the renin-angiotensin system. It is specifically suited for cardiovascular and renal workflows, and should not be used in unrelated signaling studies due to its limited solubility and defined mechanism.
-
AR and ARv7 Drive Metastasis in TNBC: EPI-001 as a Targeted
2026-05-18
This study reveals that androgen receptor (AR) and its splice variant ARv7 are associated with poor prognosis and increased metastasis in triple-negative breast cancer (TNBC). Targeting AR/ARv7 using the N-terminal domain inhibitor EPI-001 disrupts metastatic and EMT pathways, highlighting a mechanistically distinct approach for AR-driven TNBC.
-
EdU Imaging Kits (488): Precision S-Phase Profiling in Neuro
2026-05-18
Explore how EdU Imaging Kits (488) and 5-ethynyl-2'-deoxyuridine enable next-level S-phase DNA synthesis measurement for advanced cell proliferation assays. This article uniquely bridges high-sensitivity click chemistry detection with insights from neuromodulatory anti-proliferative technologies.
-
Dihydroartemisinin: Applied Protocols and mTOR Pathway Insig
2026-05-17
Dihydroartemisinin—a high-purity Artemisia plant extract—enables advanced research into malaria, inflammation, and cell signaling with robust mTOR pathway inhibition. This article delivers actionable workflows, protocol enhancements, and troubleshooting tips, translating recent reference breakthroughs into practical laboratory strategies.
-
Prednisone in Research: Deep Mechanistic Insights and Assay
2026-05-16
Explore the mechanistic depth of Prednisone, a synthetic corticosteroid, in immunology and neurodegeneration research. This article uniquely integrates molecular mechanisms, assay design considerations, and advanced metabolomics findings to guide cutting-edge experimental strategies.
451 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page